miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta.

Duonan Yu,Camila O dos Santos,Guowei Zhao,Jing Jiang,Julio D Amigo,Eugene Khandros,Louis C Dore,Yu Yao,Janine D'Souza,Zhe Zhang,Saghi Ghaffari,John Choi,Sherree Friend,Wei Tong,Jordan S Orange,Barry H Paw,Mitchell J Weiss
DOI: https://doi.org/10.1101/gad.1942110
IF: 12.89
2010-01-01
Genes & Development
Abstract:The bicistronic microRNA (miRNA) locus miR-144/451 is highly expressed during erythrocyte development, although its physiological roles are poorly understood. We show that miR-144/451 ablation in mice causes mild erythrocyte instability and increased susceptibility to damage after exposure to oxidant drugs. This phenotype is deeply conserved, as miR-451 depletion synergizes with oxidant stress to cause profound anemia in zebrafish embryos. At least some protective activities of miR-451 stem from its ability to directly suppress production of 14-3-3 zeta, a phospho-serine/threonine-binding protein that inhibits nuclear accumulation of transcription factor FoxO3, a positive regulator of erythroid anti-oxidant genes. Thus, in miR-144/451(-/-) erythroblasts, 14-3-3 zeta accumulates, causing partial relocalization of FoxO3 from nucleus to cytoplasm with dampening of its transcriptional program, including anti-oxidant-encoding genes Cat and Gpx1. Supporting this mechanism, overexpression of 14-3-3 zeta in erythroid cells and fibroblasts inhibits nuclear localization and activity of FoxO3. Moreover, shRNA suppression of 14-3-3 zeta protects miR-144/451(-/-) erythrocytes against peroxide-induced destruction, and restores catalase activity. Our findings define a novel miRNA-regulated pathway that protects erythrocytes against oxidant stress, and, more generally, illustrate how a miRNA can influence gene expression by altering the activity of a key transcription factor.
What problem does this paper attempt to address?